ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Surescripts Transforms Patient Access to Specialty Drugs, Optimizing Adherence

Increased Provider Access to Real-Time Patient Information Means Greater Efficiency, Enhanced Safety and Lower Costs

More prescribers and specialty pharmacists nationwide are adopting Surescripts Specialty Medications solutions to transform the manual process used to prescribe specialty medications, saving time and money for patients and providers.

  • In May 2022, the number of prescribers enabled for Specialty Patient Enrollment was 24% higher than in May 2021.
  • The number of Specialty Medications Gateway transactions was 421% higher in the first five months of 2022 compared to the same time period in 2021.
  • As of May 2022, specialty pharmacists can use Specialty Medications Gateway to access patient information supplied by more than 200,000 prescribers nationwide.
  • Surescripts processed 8.2 million electronic prescriptions for specialty medications between January and May 2022—an 8% increase over the same time period in 2021.
  • From January to May 2022, Surescripts delivered 85% more real-time benefit checks for specialty prescriptions compared to the same time period in 2021.
  • In May 2022, prescribers using Real-Time Prescription Benefit saved patients an average of $534.74 per specialty prescription.

“Eliminating the time-consuming and manual process of prescribing specialty medications and simplifying the delivery of patient information removes delays that threaten medication adherence,” said Frank Harvey, Chief Executive Officer of Surescripts. “It also means healthcare professionals can spend less time on paperwork and more time focused on what matters most: patients’ health.”

In January 2022, Accredo specialty pharmacy implemented automation enhancements with Specialty Medications Gateway to obtain current information for a patient’s weight for use in weight-based dosing. In just two months, Accredo reported that 60% of the time the automated workflow delivered the most recent weight for the patient, creating efficiencies and reducing manual outreach. Accredo also noted that 11% of the updated weight information was of clinical significance (+/- 10% weight change) and created an opportunity for a pharmacist to review and take action to ensure patient safety through accurate dosing.

“In caring for patients with complex diagnoses, specialty pharmacists must work with efficiency and quality,” said Katie Reeves, Senior Product Manager at Accredo. “Surescripts solutions accelerate the process for specialty prescribing, fulfillment and onboarding by filling information gaps with clinical intelligence. Speed and patient safety are enhanced because clean, critical clinical data is automatically delivered from the EHR with the prescription.”

As of May, Accredo is reviewing more than 12,000 specialty prescriptions each month that are informed by patient clinical data that is automatically pulled directly from the electronic health record. As a result, Accredo specialty pharmacists are streamlining the inefficient manual process of enrolling patients for specialty medications and ultimately delivering improved turnaround time and patient safety.

Specialty drugs account for the largest proportion of new medicines launched in the past five years, and retail prices for widely used specialty drugs increased at more than three times the rate of general inflation in 2020.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and improve the quality of care. At Surescripts, we align healthcare organizations across the nation and give healthcare professionals the trusted insights they need to serve patients. We convene the Surescripts Network Alliance® to enhance prescribing, better inform care decisions and advance healthcare as a whole. Visit us at surescripts.com and follow us at twitter.com/surescripts.

In May 2022, prescribers used Real-Time Prescription Benefit to save patients an average of $534.74 per specialty prescription. It’s helping patients with chronic or complex conditions get access to more affordable medications.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.16
-0.51 (-0.22%)
AAPL  277.55
+0.58 (0.21%)
AMD  214.24
+8.11 (3.93%)
BAC  52.99
+0.51 (0.97%)
GOOG  320.28
-3.36 (-1.04%)
META  633.61
-2.61 (-0.41%)
MSFT  485.50
+8.51 (1.78%)
NVDA  180.26
+2.44 (1.37%)
ORCL  204.96
+7.93 (4.02%)
TSLA  426.58
+7.18 (1.71%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.